4 views left Get unlimited views with a free account

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Geographic Atrophy by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 123 ongoing clinical trials involving Geographic Atrophy
Of the 123 trials,63 trials are in Phase II
Furthermore, 43 trials are in Phase III

Number of ongoing Clinical Trials (for drugs) involving Geographic Atrophy by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Geographic Atrophy, an ophthalmology indication. The largest number of ongoing clinical trials for Geographic Atrophy is conducted in North America. Europe and Asia-Pacific are among some of the other prominent regions engaged in Geographic Atrophy-related drug trials.

Gyroscope Therapeutics Holdings Ltd: The leading ongoing Geographic Atrophy related clinical trial sponsor

Gyroscope Therapeutics Holdings Ltd is the top sponsor for Geographic Atrophy-related ongoing clinical trials.

Genentech USA Inc, and NGM Biopharmaceuticals Inc are among other notable clinical trial sponsors involved in Geographic Atrophy. A clinical trial sponsor can be a Company, Government, Individual, or Institution.